Main characteristics of Asthalin HFA Inhaler 200 MD 100 mcg Cipla, active ingredients and properties
Asthalin HFA Inhaler 200 MD 100 mcg, manufactured by Cipla, is primarily designed for patients with asthma and chronic obstructive pulmonary disease (COPD). Each inhaler contains 100 mcg of the active ingredient Salbutamol, a potent bronchodilator that helps alleviate difficulty in breathing by relaxing the muscles in the airways. The HFA (hydrofluoroalkane) propellant used in this inhaler provides a more environmentally friendly option compared to older inhalers powered by chlorofluorocarbons (CFCs).
The main characteristic of Asthalin is its quick action, allowing athletes to breathe easier during intense physical activities. The inhaler’s dose can be easily administered, delivering the medication directly to the lungs, where it is most effective. This method of administration minimizes systemic side effects, enhancing its safety profile for users.
Influence on the athlete’s body, physiological effects
For athletes, Asthalin can play a pivotal role in enhancing respiratory function, particularly for those suffering from exercise-induced bronchospasm (EIB). By promoting bronchodilation, Salbutamol increases airflow, which can lead to improved oxygen uptake and enhanced endurance during physical activities. This effect is critical during high-intensity workouts or competitions, where optimal lung function is vital for performance.
Additionally, the inhaler can help control symptoms such as wheezing, coughing, and shortness of breath, allowing athletes to maintain a consistent training schedule. The immediate relief provided by the inhaler aids athletes in pushing their limits without the constant fear of respiratory discomfort hampering their performance.
Moreover, some studies suggest that the use of Salbutamol may have anabolic properties, which could translate into increased muscle mass or strength gains when combined with regular training. However, it’s essential to emphasize that athletes must use Asthalin solely under medical supervision to avoid potential misuse.
Recommendations for use, dosage and cycle duration
The standard recommendation for using the Asthalin HFA Inhaler is to administer 1-2 puffs as needed, typically before engaging in physical exertion to prevent EIB. For chronic conditions, dosages may vary based on individual needs, usually ranging from 2 to 4 puffs three to four times a day. It’s essential for athletes to consult with a healthcare provider to tailor the dosage to their specific requirements and health conditions.
Cycle duration should also be discussed with a healthcare professional, particularly in a sports environment where adherence to regulations regarding performance-enhancing substances is crucial. Regular monitoring is advisable to assess lung function and adjust usage accordingly.
How to buy Asthalin HFA Inhaler 200 MD 100 mcg Cipla safely, verified supplier and fast shipping
To purchase Asthalin HFA Inhaler 200 MD 100 mcg Cipla safely, it’s essential to select a verified supplier. Online pharmacies or medical supply stores that require a prescription are recommended to ensure product authenticity. Check reviews and ensure that the supplier complies with medical regulations.
Fast shipping options are often available, but confirm shipping policies and delivery timelines before placing an order. Reputable suppliers provide tracking information for peace of mind. Always be cautious of counterfeit products, as they may lack the efficacy and safety of the original inhaler.
Contraindications
The use of Asthalin HFA Inhaler is not recommended in certain conditions. Contraindications include:
- Hypersensitivity to Salbutamol or any components of the inhaler
- Severe cardiac disorders, including arrhythmias
- History of seizures or uncontrolled epilepsy
- Hyperthyroidism
- Diabetes Mellitus, where excessive use can lead to elevated blood sugar levels
- Pregnancy and lactation without medical advice
Always consult a healthcare provider before starting Asthalin to ensure it is appropriate for individual health conditions.








Reviews
There are no reviews yet.